BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19261799)

  • 1. Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.
    Wolter N; du Plessis M; von Gottberg A; de Gouveia L; Klugman KP
    J Clin Microbiol; 2009 May; 47(5):1319-24. PubMed ID: 19261799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
    Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.
    Mothibeli KM; du Plessis M; von Gottberg A; de Gouveia L; Adrian P; Madhi SA; Klugman KP;
    J Clin Microbiol; 2010 Jan; 48(1):184-91. PubMed ID: 19889905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
    Hsieh YC; Chang LY; Huang YC; Lin HC; Huang LM; Hsueh PR
    Clin Microbiol Infect; 2010 Jul; 16(7):973-8. PubMed ID: 19778298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan.
    Qin L; Watanabe H; Yoshimine H; Guio H; Watanabe K; Kawakami K; Iwagaki A; Nagai H; Goto H; Kuriyama T; Fukuchi Y; Matsushima T; Kudoh S; Shimada K; Matsumoto K; Nagatake T; Mizota T; Oishi K
    Epidemiol Infect; 2006 Dec; 134(6):1188-94. PubMed ID: 16650327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
    Iraurgui P; Torres MJ; Aznar J
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):180-3. PubMed ID: 22365183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.
    Johnson CN; Benjamin Jr WH; Moser SA; Hollingshead SK; Zheng X; Crain MJ; Nahm MH; Waites KB
    J Clin Microbiol; 2003 Jun; 41(6):2458-64. PubMed ID: 12791865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-typeable Streptococcus pneumoniae carriage isolates genetically similar to invasive and carriage isolates expressing capsular type 14 in Brazilian infants.
    Andrade AL; Franco CM; Lamaro-Cardoso J; André MC; Oliveira LL; Kipnis A; Rocha CG; Andrade JG; Alves SL; Park IH; Nahm MH; Almeida SG; Brandileone MC
    J Infect; 2010 Oct; 61(4):314-22. PubMed ID: 20637229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
    Adam HJ; Schurek KN; Nichol KA; Hoban CJ; Baudry TJ; Laing NM; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2007 Jan; 51(1):198-207. PubMed ID: 17088485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.
    Kasahara K; Maeda K; Mikasa K; Uno K; Takahashi K; Konishi M; Yoshimoto E; Murakawa K; Kita E; Kimura H
    J Clin Microbiol; 2005 Apr; 43(4):1640-5. PubMed ID: 15814978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.
    Pletz MW; McGee L; Jorgensen J; Beall B; Facklam RR; Whitney CG; Klugman KP
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3491-7. PubMed ID: 15328116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001.
    Davies TA; Yee YC; Goldschmidt R; Sahm DF; Evangelista AT
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):39-45. PubMed ID: 18931470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.
    Ardanuy C; Rolo D; Fenoll A; Tarrago D; Calatayud L; Liñares J
    J Antimicrob Chemother; 2009 Sep; 64(3):507-10. PubMed ID: 19535383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
    Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of antibiotic resistance among invasive and nasopharyngeal isolates of Streptococcus pneumoniae from children in rural Philippines between 1994 and 2000.
    Sombrero L; Nissinen A; Esparar G; Lindgren M; Siira L; Virolainen A;
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):929-35. PubMed ID: 18592281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.